This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • The influence of CYP3A5 and ABCB1 genotype on the ...
Clinical trial

The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of Prograf and Advagraf

Read time: 1 mins
Last updated:17th Mar 2010
The objectives of this study are 1) To determine the influence of CYP3A5 and ABCB1 genotypes on Advagraf pharmacokinetics 2) To compare the influence of these genotypes on the comparison between Prograf and Advagraf pharmacokinetics
Category Value
Study start date 2010-03-17

View full details